Mammographic and pathological features of triple-negative breast cancer

Chinese Journal of Oncology

Volumn 34, Issue 4, 2012, Pages 291-295

  Wen, Shao Yan ^a,b   Han, Yun Wei ^a,b   Ma, Xiang Min ^a,b   Zhang, Jiao ^a,b   Cui, Wen Jing ^a,b   Cao, Xu Chen ^a,b   Wang, Xin ^a,b  

^a TIANJIN MEDICAL UNIVERSITY   (China)

^b KEY LABORATORY OF CANCER PREVENTION AND THERAPY   (China)

Author keywords

Breast neoplasms; Mammographic feature; Pathologic feature; Receptor, epidermal growth factor; Receptors, estrogen; Receptors, progesterone

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR 2; ESTROGEN RECEPTOR; PROGESTERONE RECEPTOR;

ARTICLE; CANCER DIAGNOSIS; HISTOPATHOLOGY; HUMAN; MAJOR CLINICAL STUDY; MAMMOGRAPHY; RETROSPECTIVE STUDY; TRIPLE NEGATIVE BREAST CANCER; TUMOR CALCINOSIS; TUMOR VOLUME;

ADULT; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; FEMALE; HUMANS; LYMPHATIC METASTASIS; MAMMOGRAPHY; MIDDLE AGED; NEOPLASM GRADING; RECEPTOR, ERBB-2; RECEPTORS, ESTROGEN; RECEPTORS, PROGESTERONE; RETROSPECTIVE STUDIES;

EID: 84862106776     PISSN: 02533766     EISSN: None     Source Type: Journal    
DOI: 10.3760/cma.j.issn.0253-3766.2012.04.012     Document Type: Article

References (17)

1. Hanley KZ, Birdsong GG, Cohen C, et al. Immunohistochemical detection of estrogen receptor, progesterone receptor, and human epidermal growth factor receptor 2 expression in breast carcinomas: comparison on cell block, needle-core, and tissue block preparations. Cancer, 2009, 117:279-288.
2. Wang Y, Ikeda DM, Narasimhan B, et al. Estrogen receptor-negative invasive breast cancer: imaging features of tumors with and without human epidermal growth factor receptor type 2 overexpression. Radiology, 2008, 246:367-375.
3. Karamouzis MV, Likaki-Karatza E, Ravazoula P, et al. Non-palpable breast carcinomas: correlation of mammographically detected malignant-appearing microcalcifications and molecular prognostic factors. Int J Cancer, 2002, 102:86-90.
4. Ildefonso C, Vazquez J, Guinea O, et al. The mammographic appearance of breast carcinomas of invasive ductal type: relationship with clinicopathological parameters, biological features and prognosis. Eur J Obstet Gynecol Reprod Biol, 2008, 136:224-231. (Pubitemid 351173443)
5. Sickles EA. Breast masses: mammographic evaluation. Radiology, 1989, 173:297-303. (Pubitemid 19264573)
6. Liberman L, Morris EA, Lee MJ, et al. Breast lesions detected on MR imaging: features and positive predictive value. AJR Am J Roentgenol, 2002, 179:171-178. (Pubitemid 34694831)
7. Paradiso A, Mangia A, Barletta A, et al. Mammography and morphobiologic characteristics of human breast cancer. Tumori, 1993, 79:422-426. (Pubitemid 24124191)
8. Lamb PM, Perry NM, Vinnicombe SJ, et al. Correlation between ultrasound characteristics, mammographic findings and histological grade in patients with invasive ductal carcinoma of the breast. Clin Radiol, 2000, 55:40-44. (Pubitemid 30255698)
9. Jiang L, Ma T, Moran MS, et al. Mammographic features are associated with clinicopathological characteristics in invasive breast cancer. Anticancer Res, 2011, 31:2327-2334.
10. Kim MJ, Ro JY, Ahn SH, et al. Clinicopathologic significance of the basal-like subtype of breast cancer: a comparison with hormone receptor and Her2/neu-overexpressing phenotypes. Hum Pathol, 2006, 37:1217-1226. (Pubitemid 44286991)
11. Hong AS, Rosen EL, Soo MS, et al. BI-RADS for sonography: positive and negative predictive values of sonographic features. AJR Am J Roentgenol, 2005, 184:1260-1265. (Pubitemid 43821910)
12. Rakha EA, El-Sayed ME, Green AR, et al. Prognostic markers in triple-negative breast cancer. Cancer, 2007, 109:25-32. (Pubitemid 46120191)
13. Hamilton LJ, Evans AJ, Wilson AR, et al. Breast imaging findings in women with BRCA1- and BRCA2-associated breast carcinoma. Clin Radiol, 2004, 59:895-902. (Pubitemid 39276928)
14. Seo BK, Pisano ED, Kuzimak CM, et al. Correlation of HER-2/neu overexpression with mammography and age distribution in primary breast carcinomas. Acad Radiol, 2006, 13:1211-1218. (Pubitemid 44363165)
15. Tabar L, Tony Chen HH, Amy Yen MF, et al. Mammographic tumor features can predict long-term outcomes reliably in women with 1-14-mm invasive breast carcinoma. Cancer, 2004, 101:1745-1759.
16. Munzone E, Curigliano G, Rocca A, et al. Reverting estrogen-receptor- negative phenotype in HER-2-overexpressing advanced breast cancer patients exposed to trastuzumab plus chemotherapy. Breast Cancer Res, 2006, 8:R4.